Stella Artois and Budweiser brewers to develop new cannabis beverages
After the manufacturers of Heineken and Corona, manufacturers of beer brands Stella-Artois and Budweiser also enter the field of cannabis. In collaboration with the Canadian cannabis company Tillray, they will develop a non-alcoholic cannabis containing THC and CBD.
Stella Artois & Budweiser enter the cannabis industry
The Belgian company AB InBev, owner of famous beer brands such as Budweiser, Stella Artois and others, enters the cannabis market for a total of 100 million.
The company announced early this morning that it is cooperating with Canadian society Tilray Cilabis, which at the beginning of the week also announced for cooperation with the pharmaceutical giant Novartis.
The two companies will jointly invest up to 100 million dollars in the research and development of new beverages containing cannabis and its components, cannabinoids THC and CBD.
At the same time, they announced that, as a first step, their new cooperation would only focus on development and was not yet in production. If imported in the future, both companies will receive an additional investment of 1 million dollars each.
The research will be conducted by Labatt Breweries, a Canadian subsidiary of InBev, and High Park, a Canadian subsidiary of Tillray.
"We intend to develop a thorough knowledge of non-alcoholic beverages containing THC and CBD," said a press release from Breweries president Kyle Norrington.
"This will be the basis for any future decisions regarding the marketing of the products."
Following this announcement, Tilray's shares jumped 15%. Tilray currently operates in 12 countries around the world, including Australia, New Zealand, Canada, Germany, South America and Portugal.